EN DE
STOCK COMPARISON

Puriblood Medical Co. vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Puriblood Medical Co. (6847) and Thermo Fisher Scientific (TMO) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Puriblood Medical Co. as the less overvalued of the two: Puriblood Medical Co. trades at TWD 78.50 versus a fair value of TWD 61.52 (-22%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).
Puriblood Medical Co.
6847.TWO · TWD · Healthcare
-22%
upside to fair value
overvalued
PriceTWD 78.50
Fair ValueTWD 61.52
Quality47/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$594
Fair Value$308
Quality63/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Puriblood Medical Co.Thermo Fisher Scientific
Valuation
P/E (TTM)29.5×
0.39×P/S (TTM)4.41×
0.23×P/B3.74×
EV/EBITDA20.0×
PEG1.74×
Dividend yield0.3%
Dividend per share$1.76
Profitability
-47%Net margin15%
-54%Operating margin18%
-25%Return on equity14%
-8%Return on assets5%
Growth
-45%Revenue growth (YoY)6%
-15.7%Avg. growth/yr (3Y)-0.3%
16.3%Avg. growth/yr (5Y)6.7%
Balance & size
0.13×Debt / equity0.67×
$32MMarket cap$199B
expensiveGrowth qualityhealthy

Thermo Fisher Scientific leads: 4 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Puriblood Medical Co.of which business quality 47 · market factors 58 Thermo Fisher Scientificof which business quality 60 · market factors 65
ProfitabilityMargins and returns on capital today
8
43
Quality GrowthAre margins and returns improving?
22
31
CashflowEarnings quality: real cash, not paper profit
5
62
Fin. StrengthBalance sheet, leverage, solvency risk
91
60
InvestmentDisciplined investing over empire-building
100
79
Low VolatilityCalm price path (market factor)
50
68
MomentumPrice trend over the last 3–12 months (market factor)
61
58
52W MomentumDistance to the 52-week high (market factor)
62
72
Net IssuanceBuybacks instead of dilution
82
97

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Puriblood Medical Co.

Asset-BasedTWD 6.60

1 of 1 models see the stock below the current price.

Thermo Fisher Scientific

DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Puriblood Medical Co.
Bear TWD 40.80Fair Value TWD 61.52Bull TWD 77.06
TWD 78.50 = current price (white tick)
Thermo Fisher Scientific
Bear $175Fair Value $308Bull $385
$594 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Puriblood Medical Co. · Healthcare

Quality score47 · below median
Fair value upside-22% · above median

Thermo Fisher Scientific · Health Care

Quality score63 · above median
Fair value upside-48% · below median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Puriblood Medical Co. as the less overvalued of the two: Puriblood Medical Co. trades at TWD 78.50 versus a fair value of TWD 61.52 (-22%), while Thermo Fisher Scientific trades at $594 versus $308 (-48%).

Thermo Fisher Scientific has the higher quality score (63/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.